Financial statements ICAP plc 85 Annual Report 2007 16 Investment in associates As at As at 31 March 31 March 2007 2006 m m Cost As at 1 April 37.3 12.3 Additions 3.5 20.1 Revaluation of investments to fair value 3.0 2.3 Share of profit for the financial year 6.0 3.4 Dividends received 3.9 0.8 Transfer to available-for-sale investments note 17 10.3 Exchange adjustments 0.1 As at 31 March 35.5 37.3 Amortisation and impairment As at 1 April 4.2 3.4 Amortisation charge for the year 1.7 0.6 Transfer to available-for-sale investments note 17 0.2 Impairment in the year 0.2 As at 31 March 5.7 4.2 Net book value As at 31 March 29.8 33.1 The addition in the year of 3.5m is due to the acquisition of an additional 11% in TriOptima AB which increased the Groups holding to 39.99%.
The additions in 2006 include 20.0m arising from the acquisition of a 25.1% interest in BSN note 13 c. During the year the Group reduced its equity voting rights in CIMD from 25.5% to 19.99% while retaining the right to 25.5% of profits.
Accordingly, the Group no longer exerts a significant influence over the company and the investment has been transferred to available-for-sale investments.
The Group has recognised no gain or loss.
Summary financial information for associates The Groups share of associates assets, liabilities and profit is given below: As at As at 31 March 31 March 2007 2006 m m Assets 6,856.7 5,981.3 Liabilities 6,849.4 5,969.0 Net assets 7.3 12.3 Goodwill and intangible assets arising on consolidation 22.5 20.8 Net investment in associates 29.8 33.1
